Results 41 to 50 of about 2,238 (188)
The majority of hemolytic disease of the fetus and newborn (HDFN) reported in the literature is due to ABO and rhesus incompatibility. However, there are also other minor blood groups that have been identified as a cause of HDFN, although the occurrence ...
Salfarina Iberahim +6 more
doaj +1 more source
Anti-S antibodies: an unusual cause of haemolytic disease of the fetus and newborn (HDFN) [PDF]
We report a case of haemolytic disease of the fetus and newborn due to anti-S antibodies. Baby G was born by emergency caesarean section at 35 weeks due to reduced fetal movement. Prior to delivery, antenatal screening revealed the mother's blood group was AB rhesus positive with anti-S antibody titres.
Christopher, Pitan +4 more
openaire +2 more sources
Update on HDFN: new information on long-standing controversies [PDF]
Abstract Hemolytic disease of the fetus and newborn (HDFN) results from maternal IgG antibodies that cross the placenta to the fetal circulation during gestation and cause RBC destruction and complications before birth (HDF), or anemia and hyperbilirubinemia after birth (HDN), or both. In its most severe form, HDF
openaire +2 more sources
Necrotizing enterocolitis in haemolytic disease of the newborn: a retrospective cohort study [PDF]
Background and objectives Necrotizing enterocolitis (NEC) is a common and often severe gastrointestinal emergency in newborn infants. While usually affecting (very) premature infants, an association between NEC and haemolytic disease of the foetus and ...
Ree, I.M.C. +7 more
core +1 more source
Objective To explore the correlation between the severity of jaundice in ABO hemolytic disease of fetus and newborn (HDFN) and multiple indicators, in order to achieve accurate diagnosis, timely treatment, and prevent complications in ABO HDFN.
Ronghua XU +6 more
doaj +1 more source
BACKGROUND: The clinical significance of serologic reactivity of unidentified specificity (SRUS) in pregnancy is not clear based on available literature.
Scally, Edel +41 more
core +1 more source
Third trimester screening for alloimmunisation in Rhc-negative pregnant women:evaluation of the Dutch national screening programme [PDF]
ObjectiveTo evaluate the effect of red blood cell (RBC) antibody screening in the 27th week of pregnancy in Rhc-negative women, on detection of alloimmunisation, undetected at first trimester screening (late' alloimmunisation), and subsequent haemolytic ...
de Haas, M. +10 more
core +1 more source
Study of Haemolytic Disease of the Foetus and Newborn with Positive Direct Coomb’s Test in Single Centre [PDF]
Objectives: HDFN is caused by maternal alloantibodies against foetal erythrocytes that might cause morbidity and mortality in the foetus and newborn. Our study aims to investigate the incidence of Haemolytic disease of foetus and newborn (HDFN), Direct ...
Yasser OSMANA, Mashael ALKHALDIA
doaj +1 more source
Alloimmunisation during pregnancy in Greece: need for nationwide
SUMMARYAim/ObjectivesTo access the incidence and specificity of maternal red blood cells alloimmunisation and its relevant clinical impact in Greece.BackgroundThe rate of alloimmunisation in pregnant women in Greece is unknown.Materials/MethodsWe performed a 4‐year study in two tertiary hospitals in Greece.
Foudoulaki-Paparizos, L. +7 more
openaire +3 more sources
Background: Hemolytic disease of the fetus and newborn (HDFN) can cause severe prenatal and postnatal outcomes. The main objective of this study is to characterize the clinical impact of HDFN on pregnant women and their newborns.
Noga Fallach +11 more
doaj +1 more source

